Physical Agent-Based Treatments for Overactive Bladder: A Review
- PMID: 36079076
- PMCID: PMC9456779
- DOI: 10.3390/jcm11175150
Physical Agent-Based Treatments for Overactive Bladder: A Review
Abstract
Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition is first managed by reducing fluid intake and pelvic floor muscle training, supplemented with antimuscarinic drugs, if necessary. However, refractory cases often still occur. In more severe cases, invasive surgical interventions can be considered; yet, the success rate is still inconsistent, and there is a high complication rate. This condition is frustrating for patients and challenging for the medical staff involved. Although its pathophysiology has not been fully elucidated, peripheral autonomic somatic and sensory afferent receptors are considered to be involved in this condition. Hence, currently, physical agent-based treatments such as neuromodulation have taken a significant place in the third-line therapy of OAB. The efficacy and safety profiles of electrical and magnetic stimulation continue to evolve. Physical-based agents provide an appealing option owing to their effectiveness and minimal side effects. In addition, more physical therapies using light and shock energy are currently being investigated. Thus, a comprehensive understanding of these modalities is an extremely important aspect to provide the most suitable modalities for patients.
Keywords: electrical stimulation; laser; low-intensity shock energy; magnetic stimulation; neuromodulation; overactive bladder; physical-based agent.
Conflict of interest statement
All authors declare no conflict of interest.
Figures


Similar articles
-
Overactive bladder--a practical approach to evaluation and management.J Med Liban. 2004 Oct-Dec;52(4):220-6. J Med Liban. 2004. PMID: 16432986 Review.
-
Management of overactive bladder.Nat Rev Urol. 2010 Oct;7(10):572-82. doi: 10.1038/nrurol.2010.147. Nat Rev Urol. 2010. PMID: 20930868 Review.
-
Pathophysiology of refractory overactive bladder.Low Urin Tract Symptoms. 2019 Sep;11(4):177-181. doi: 10.1111/luts.12262. Epub 2019 Mar 22. Low Urin Tract Symptoms. 2019. PMID: 30900373 Review.
-
A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being.Prz Menopauzalny. 2019 Jun;18(2):89-93. doi: 10.5114/pm.2019.86834. Epub 2019 Jun 28. Prz Menopauzalny. 2019. PMID: 31485205 Free PMC article. Review.
-
Management of OAB in those over age 65.Curr Urol Rep. 2013 Oct;14(5):379-85. doi: 10.1007/s11934-013-0338-5. Curr Urol Rep. 2013. PMID: 23922134 Review.
Cited by
-
Progress in Functional Urology Reflected in Recent Papers in the Journal of Clinical Medicine.J Clin Med. 2023 Jul 4;12(13):4482. doi: 10.3390/jcm12134482. J Clin Med. 2023. PMID: 37445516 Free PMC article.
-
Special Issue: "Latest Advances on Urinary Incontinence".J Clin Med. 2023 Nov 14;12(22):7075. doi: 10.3390/jcm12227075. J Clin Med. 2023. PMID: 38002688 Free PMC article.
-
Sacral magnetic neuromodulation with intermittent theta burst waveform enhances overactive bladder: In vivo study.Biomed J. 2025 Jun;48(3):100775. doi: 10.1016/j.bj.2024.100775. Epub 2024 Jul 25. Biomed J. 2025. PMID: 39059583 Free PMC article.
-
Effectiveness of transcutaneous tibial nerve stimulation on overactive bladder treatment.Pak J Med Sci. 2025 Jun;41(6):1629-1637. doi: 10.12669/pjms.41.6.11658. Pak J Med Sci. 2025. PMID: 40621528 Free PMC article.
References
-
- Irwin D.E., Milsom I., Hunskaar S., Reilly K., Kopp Z., Herschorn S., Coyne K., Kelleher C., Hampel C., Artibani W., et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur. Urol. 2006;50:1306–1314. doi: 10.1016/j.eururo.2006.09.019. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources